19 May 2009 - Argenta Discovery has announced a milestone in its joint chronic obstructive pulmonary disease (COPD) bronchodilator drug programme with Astrazeneca.
This milestone marks the first candidate drug from the collaboration to enter Phase I safety and tolerability studies.
